Our Real World Evidence Analyst and Data Management team has grown and we are delighted to welcome, Mike, Maria, Samira, Ting and Raj to the pH family! Mike Wallington – Epidemiologist Mike has extensive experience from a range of roles across the health service, working for over eight years in cancer intelligence with Public Health England,…
We are proud to announce that Georgina Nock, Associate Director at pH Associates (an OPEN Health company), has been appointed as Chair for the Late Phase Working Group of EUCROF. The objective of EUCROF (the European CRO Federation), a non-profit organization founded in 2005, is to promote Clinical Research by improving the knowledge, competence/expertise and…
This year pH Associates are not only exhibiting at ISPOR stand 715, but together with our sister companies OPEN Access Consulting and Harvey Walsh will be presenting 10 posters covering research on current topics in market access, patient centred outcomes and real world evidence. Monday 12th November Poster Session I (08:45 – 13:45) PCP65:…
Healthcare systems are complex and highly varied from one country to the next. With significant advances in technologies these systems need to be able to adapt and evolve in order to continually deliver the best care to patients. It is therefore fitting that the focus of the 2018 European ISPOR Congress will be on…
Digital therapeutics, when created empathetically to patients and health care professionals (HCPs), can show significant value to all stakeholders in the healthcare pathway [1]. A question at a recent NHS conference prompted an important question: if pharma is funding these innovations with a commercial motivation, how do you ensure equality in access to digital therapeutics?…
The key differentiator between ‘digital health and wellbeing technologies’ and ‘digital therapeutics’ is that the latter must show improved outcomes. Approximately 140 studies were published in 2017 which contained clinical evidence of digital health efficacy [1]. Clinically validated technologies have looked to show value for health systems by reducing emergency hospitalisation, A&E, ambulatory, drug and…
Digital therapeutics do not yet have a widely agreed definition, though the market for them is expected to reach $9 billion by 2025. Their rise coincides with the intensification of the digital health market as a whole in recent years, which includes the widespread use of health and wellbeing technologies including fitness, sleep and diet…
pH Associates is a strategic Real World Evidence (RWE) consultancy that works collaboratively with industry, the NHS and academia to create projects that drive improvement in healthcare delivery. OPEN Health sit down with Sam Oliver, Joint Managing Director at pH associates to answer the following questions: What is Real World Evidence? How do we work with…
pH Associates is delighted to welcome Abi, Toby, Nancy and Jen to the pH family! Abi Mawer joins pH as an Associate Real-World Evidence Consultant. Abi has 5 years consulting experience and has worked in Harvey Walsh and The EarthWorks within the OPEN Health group. Abi has a BSc in Biomedical Sciences and an MSc…
pH Associates were delighted to meet with current and former clients at the NICE Conference #NICEConf18 last week and to have the opportunity to attend some thought-provoking breakout sessions. Of particular interest was a topical session focused on ‘Tackling Antimicrobial Resistance Globally and Locally’, with Nick Crabb (Programme Director, Scientific Affairs, NICE), Susan Hopkins (Chair…
